Torrent Pharmaceuticals

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, owned by Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Acyclovir	Acyclovir	2019-01-11	2027-2030	Herpes zoster , Epstein-barr virus infections , Herpes simplex , Herpes labialis , Herpes simplex encephalitis , Aids-related opportunistic infections , Herpes genitalis , Chickenpox , Herpes zoster ophthalmicus , Shock , Ulcerative colitis , Pruritus ani , Inflammation , Adrenal insufficiency , Rheumatic diseases , Status asthmaticus , Contact dermatitis , Facial dermatoses , Hemorrhoids , Congenital adrenal hyperplasia , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Alfuzosin	Alfuzosin	2011-07-18		Prostatic hyperplasia
Amlodipine besylate	Amlodipine besylate	2008-09-22		—
Amlodipine besylate valsartan	Amlodipine besylate, Valsartan	2015-03-30	2023-2036	Heart failure , Diabetic nephropathies , Hypertension , Left ventricular dysfunction , Coronary artery disease , Variant angina pectoris , Nephrotic syndrome , Edema , Malignant hypertension
Amlodipine besylate, valsartan hydrochlorothiazide	Amlodipine besylate, Hydrochlorothiazide, Valsartan	2015-06-03	2023-2028	Heart failure, Diabetic nephropathies, Hypertension, Left ventricular dysfunction, Nephrotic syndrome, Edema, Coronary artery disease, Variant angina pectoris, Essential hypertension, Cystic fibrosis, Hypokalemia, Ascites, Polyuria, Myocardial infarction, Angina pectoris, Supraventricular tachycardia, Rheumatoid arthritis, Raynaud disease, Malignant hypertension, Bartter syndrome, Pulmonary hypertension, Dyskinesias, Schizophrenia, Left ventricular hypertrophy, Pheochromocytoma, Ventricular tachycardia, Essential tremor, Esophageal and gastric varices, Ventricular fibrillation, Panic disorder, Hyperaldosteronism, Hirsutism, Atrial fibrillation, Atrial flutter, Open-angle glaucoma
Amlodipine olmesartan medoxomil	Amlodipine besylate, Olmesartan medoxomil	2016-11-25		—
Anagrelide	Anagrelide	2017-06-30		Essential thrombocythemia, Polycythemia vera, Thrombocytosis
Aprepitant	Aprepitant	2020-10-21	2027-2035	Neoplasms, Postoperative nausea and vomiting, Vomiting
Aripiprazole	Aripiprazole	2015-04-28	2023-2034	Schizophrenia, Bipolar disorder, Schizophrenia spectrum and other psychotic disorders
Bupropion	Bupropion	2014-10-31	2024-2043	Obesity, Alcoholism, Opioid-related disorders, Tobacco use disorder, Overweight, Drug overdose, Attention deficit disorder with hyperactivity, Depressive disorder, Cough
Carbamazepine	Carbamazepine	2001-07-05	2024-2040	Substance withdrawal syndrome, Restless legs syndrome, Trigeminal neuralgia, Complex partial epilepsy, Tonic-clonic epilepsy, Schizophrenia, Psychotic disorders, Bipolar disorder, Post-traumatic stress disorders, Mood disorders
Celecoxib	Celecoxib	2015-12-23	2029-2038	Ankylosing spondylitis, Rheumatoid arthritis, Osteoarthritis, Adenomatous polyposis coli, Dysmenorrhea, Hypertension, Coronary artery disease, Variant angina pectoris, Pain
Cetirizine	Cetirizine	2010-04-15	2030-2032	Allergic rhinitis perennial, Urticaria, Sinusitis, Asthma, Common cold
Citalopram	Citalopram	2007-03-27		Alcoholism, Tobacco use disorder, Diabetic neuropathies, Dementia, Obsessive-compulsive disorder, Depressive disorder

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication